Publication | Open Access
Cabozantinib and Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer
22
Citations
36
References
2021
Year
The combination of cabozantinib and panitumumab has activity. Dose reductions of cabozantinib improve tolerability.
| Year | Citations | |
|---|---|---|
Page 1
Page 1